Literature DB >> 16564043

Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.

Naotoshi Sugimoto1, Noriko Takuwa, Kazuaki Yoshioka, Yoh Takuwa.   

Abstract

Lysophosphatidic acid (LPA) is a major serum lysophospholipid that stimulates cell migration in diverse cell types including ovarian cancer cells. We report here that in the absence of Gi function, LPA induces inhibition, rather than stimulation, of cellular Rac activity, lamellipodium formation, and cell migration in response to insulin like growth factor I (IGF-I) in Chinese hamster ovary (CHO) cells, which solely express LPA1 as a LPA receptor. The inhibitory effects of LPA are abrogated by the expression of either Galpha13 C-terminal peptide or C3 toxin pretreatment, but not a Rho kinase inhibitor. Without PTX pretreatment, LPA stimulates Rac and cell migration yet similarly activates Rho, indicating that Rho activation by itself is not sufficient for inhibition of cell migration. Conversely, the expression of a dominant negative Rac mutant sufficiently mimics the LPA inhibition of cell migration. LPA inhibits IGF I-induced Akt activation by only 40% in a manner dependent on Rho kinase. These results demonstrate that inhibition of Gi function converts LPA regulation on Rac and cell migration to an inhibitory mode, which is mediated by G13 and Rho but not Rho kinase, and raise a possibility of Gi as a new therapeutic target for LPA-dependent tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564043     DOI: 10.1016/j.yexcr.2006.02.020

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

Review 1.  Big roles for small GTPases in the control of directed cell movement.

Authors:  Pascale G Charest; Richard A Firtel
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

2.  Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation.

Authors:  Heike Stachelscheid; Hady Ibrahim; Linda Koch; Annika Schmitz; Michael Tscharntke; F Thomas Wunderlich; Jeanie Scott; Christian Michels; Claudia Wickenhauser; Ingo Haase; Jens C Brüning; Carien M Niessen
Journal:  EMBO J       Date:  2008-07-24       Impact factor: 11.598

3.  RanBPM protein acts as a negative regulator of BLT2 receptor to attenuate BLT2-mediated cell motility.

Authors:  Jun-Dong Wei; Joo-Young Kim; Ae-Kyoung Kim; Sung Key Jang; Jae-Hong Kim
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

4.  RhoA protects the mouse heart against ischemia/reperfusion injury.

Authors:  Sunny Yang Xiang; Davy Vanhoutte; Dominic P Del Re; Nicole H Purcell; Haiyun Ling; Indroneal Banerjee; Julie Bossuyt; Richard A Lang; Yi Zheng; Scot J Matkovich; Shigeki Miyamoto; Jeffery D Molkentin; Gerald W Dorn; Joan Heller Brown
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

5.  RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.

Authors:  Jessica Lauriol; Kimberly Keith; Fabrice Jaffré; Anthony Couvillon; Abdel Saci; Sanjeewa A Goonasekera; Jason R McCarthy; Chase W Kessinger; Jianxun Wang; Qingen Ke; Peter M Kang; Jeffery D Molkentin; Christopher Carpenter; Maria I Kontaridis
Journal:  Sci Signal       Date:  2014-10-21       Impact factor: 8.192

6.  Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival.

Authors:  Danielle M Lapierre; Natsuko Tanabe; Alexey Pereverzev; Martha Spencer; Ryan P P Shugg; S Jeffrey Dixon; Stephen M Sims
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

7.  Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.

Authors:  Zendra Lee; Ching-Ting Cheng; Helen Zhang; Mark A Subler; Jinhua Wu; Abir Mukherjee; Jolene J Windle; Ching-Kang Chen; Xianjun Fang
Journal:  Mol Biol Cell       Date:  2008-10-08       Impact factor: 4.138

8.  Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.

Authors:  Kang Jin Jeong; Soon Young Park; Ji Hye Seo; Kyung Bok Lee; Wahn Soo Choi; Jeung Whan Han; Jae Ku Kang; Chang Gyo Park; Yong Kee Kim; Hoi Young Lee
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

9.  Lysophospholipid signaling: beyond the EDGs.

Authors:  William J Valentine; Yuko Fujiwara; Ryoko Tsukahara; Gabor Tigyi
Journal:  Biochim Biophys Acta       Date:  2007-08-25

10.  Phosphodiesterase inhibitors suppress Lactobacillus casei cell-wall-induced NF-κB and MAPK activations and cell proliferation through protein kinase A--or exchange protein activated by cAMP-dependent signal pathway.

Authors:  Takekatsu Saito; Naotoshi Sugimoto; Kunio Ohta; Tohru Shimizu; Kaori Ohtani; Yuko Nakayama; Taichi Nakamura; Yashiaki Hitomi; Hiroyuki Nakamura; Shoichi Koizumi; Akihiro Yachie
Journal:  ScientificWorldJournal       Date:  2012-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.